coomassie brilliant blue has been researched along with Nephritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreira, AL; Cardoso, LR; Coutinho-Silva, R; Gomes, CR; Leite, M; Miranda, LC; Morales, MM; Ornellas, DS; Ornellas, FM; Pereira, JMS; Schanaider, A; Takiya, CM | 1 |
1 other study(ies) available for coomassie brilliant blue and Nephritis
| Article | Year |
|---|---|
Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apoptosis; Cell Movement; Cell Proliferation; Collagen Type I; Collagen Type III; Collagen Type IV; Fibrosis; HSP47 Heat-Shock Proteins; Interleukin-1beta; Kidney; Kidney Tubules; Macrophages; Male; Myofibroblasts; Nephritis; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; RNA, Messenger; Rosaniline Dyes; Time Factors; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction | 2020 |